ADENOID CYSTIC CARCINOMA
Clinical trials for ADENOID CYSTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOID CYSTIC CARCINOMA trials appear
Sign up with your email to follow new studies for ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare salivary gland cancer
Disease control OngoingThis study tests a combination of two drugs—pemetrexed (chemotherapy) and pembrolizumab (immunotherapy)—in people whose salivary gland cancer has returned or spread. The goal is to see if this combo can shrink tumors or slow the disease. The study includes 45 adults with advanced…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 02:18 UTC
-
Immunotherapy duo takes on 50+ rare cancers in major trial
Disease control OngoingThis phase 2 trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) in over 800 people with more than 50 types of rare cancers. The goal is to see if this treatment can shrink tumors by helping the immune system attack cancer cells. The study is for patie…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Experimental drug AL101 shows promise in shrinking rare cancer before surgery
Disease control OngoingThis early-phase trial tests the safety and potential benefits of the drug AL101 given before standard surgery for people with a rare salivary gland cancer called adenoid cystic carcinoma that has a specific genetic change (NOTCH activation). The study involves 14 adults whose ca…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New drug combo shows promise for rare salivary gland cancers
Disease control OngoingThis study tests whether two drugs, lenvatinib and pembrolizumab, can shrink or slow the growth of advanced salivary gland cancers that have spread or come back. About 64 adults with adenoid cystic carcinoma or other salivary gland cancers will take part. The goal is to see how w…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC